HIF1A and retinal degeneration: Evidence shows that HIF1A can be safely inactivated in cones (see above), rods ([38], Barben et al., submitted) and RPE [75] suggesting that targeting HIF transcription factors in photoreceptors and RPE may provide a potential therapeutic approach to rescue hypoxia-mediated retinal degeneration in patients and an alternative to anti-VEGF agents.